ETF Exchange > BBC ETF
BBC - ETF Fact Sheet
Virtus LifeSci Biotech Clinical Trials ETF - USD
Fund Identification
Ticker
BBC
ISIN
US26923G3011
Main Metrics
Price
$51.14Expense Ratio
0.65%AuM
$51.14MTracking Difference
-3.85%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
BBC's historical prices, performance, and flows
1m returns
19%
1m flows
$3M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all BBC data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
BBC's characteristics
Manager
Manager statistics
24 funds, $2.87Bn in AUM
Benchmark
LifeSci Biotechnology Clinical Trials Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
BBC's exposure
Countries
USA
87.33%
Other
12.67%
Sectors
Healthcare
100.00%
Top 5 holdings
Enliven Therapeutics, Inc.
1.96%
Spyre Therapeutics, Inc.
1.70%
Tango Therapeutics, Inc.
1.67%
Dianthus Therapeutics, Inc.
1.60%
Revolution Medicines, Inc.
1.53%
Total holdings
117
Total weight of top 5
8.47%
